Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA to discuss Menaflex device, gives more time for feedback on 510(k) process

This article was originally published in RAJ Devices

Executive Summary

The Orthopaedic and Rehabilitation Devices Panel of the US Food and Drug Administration’s Medical Devices Advisory Committee will meet on 23 March to discuss and make recommendations on the agency’s re-evaluation of ReGen Biologic’s collagen scaffold device, Menaflex1.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC095963

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel